Data Foundry

Medical device recalls 2012

BD GeneOhm Cdiff Assay — Class II medical device recall Z-2318-2012

Terminated recall by Becton Dickinson & Co., reported 2012-09-12, distributed nationwide. Leakage in Cepheid SmartCycler reaction tubes.

Recall numberZ-2318-2012
Product typeMedical device
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmBecton Dickinson & Co., Sparks, MD, United States
Recall initiated2012-05-22
Classified2012-09-06
Reported by FDA2012-09-12
Terminated2012-11-02
DistributedNationwide (US)
Quantity57 kits
Reason classespackaging
Lot numbers08T11248, 08T11251
Model numbers200, 441400

Product

BD GeneOhm Cdiff Assay , Catalog #441400 200, box tests 1-3 labeled in part***BD Diagnostics, 2555 boul, du Parc-Technologique, Quebec, QC, Canada G1P 4S5*** BD GeneOhm Cdiff Assay is a qualitative in vitro diagnostic test for the direct detection of C. difficile toxin gene (tcdB) in human liquid or soft stool specimens fr.om patients suspected of having Clostridium difficile-associated disease (CDAD). The test, based on real-time PCR, is intended for use as an aid in diagnosis of CDAD. The test is performed directly on the specimen, utilizing polymerase chain reaction (PCR) for the amplification of specific targets and fluorogenic target-specific hybridization probes for the detection of the amplified DNA.

Reason for recall

Leakage in Cepheid SmartCycler reaction tubes.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-2318-2012. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.